(Q84268424)
Statements
Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14(++)CD16(+)/CD14(+)CD16(++)) monocytes in rheumatoid arthritis patient (English)
Karolina Bukowska-Strakova
Mariusz Korkosz